Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BraveCX

K-Number: K223754 · 2023-11-09

ApplicantBering, Ltd.
Decision Date2023-11-09
Product CodeQFM
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

BraveCX is a medical device manufactured by Bering, Ltd.. It received FDA 510(k) clearance on 2023-11-09 under approval number K223754. The device is classified under product code QFM. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BraveCX?

BraveCX is a medical device that received FDA 510(k) clearance on 2023-11-09. It is manufactured by Bering, Ltd.. The 510(k) number is K223754.

When was BraveCX approved by the FDA?

BraveCX received FDA 510(k) clearance on 2023-11-09, under approval number K223754.

What company makes BraveCX?

BraveCX is manufactured by Bering, Ltd..

What is the FDA product code for BraveCX?

The FDA product code for BraveCX is QFM.

Related Devices (Code: QFM)

K192320HealthCXRZebra Medical Vision, Ltd. K183182Critical Care SuiteGe Medical Systems, LLC K190362HealthPNXZebra Medical Vision, Ltd. K183285cmTriageCuremetrix, Inc. K200905HealthMammoZebra Medical Vision, Ltd. K192901HealthVCFZebra Medical Vision, Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑